secwatch.observer — SEC 8-K summary
======================================

Issuer:     Skye Bioscience, Inc. (SKYE)
CIK:        0001516551
Form:       8-K
Filed at:   2024-07-03T23:59:59+00:00
Accession:  0001516551-24-000064
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Skye Bioscience appoints Dr. Karen Smith to board; two directors resign effective Aug 1
--------------------------------------------------------------------------------

- Appoints Dr. Karen Smith MD, PhD, MBA, LLM to board; retainer $40k/yr plus committee fees and 40,000-share option.
- Drs. Keith Ward and Praveen Tyle resign from board effective Aug 1, 2024; no disagreement with company.
- Grants new General Counsel Brennen Brodersen inducement award: option for 60,000 shares and 15,000 RSUs.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1516551/000151655124000064/0001516551-24-000064-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1516551/000151655124000064/skye-20240701.htm
  HTML page:      https://secwatch.observer/filing/0001516551-24-000064

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer